IFM Investors denies misleading key Parliamentary Committee

Industry funds backed investment manager, IFM Investors has strongly denied to a Parliamentary Committee that it overvalued an investment in a Mexican energy company, Aleatica Mexico, when giving evidence to the committee last year.

IFM Investors was challenged on the issue by the chair of the House of Representatives Standing Committee on Economics, Tim Wilson, after specialist research house, Aurora Research, produced a report claiming that IFM Investors misled the committee when it denied it was valuing its stake in Aleatica Mexico at a substantial premium to its share price.

According to the Aurora Research claims, an IFM Investors executive had falsely denied to the committee that IFM valued its investment in Aleatica Mexico at around $3.79 AUD per share, when those same shares were listed in Mexico’s stock exchange at a quoted price of around $1.52 AUD per share.

Related News:

As chair of the committee, Wilson promptly sent off a question on notice to IFM Investors asking for an explanation.

IFM’s global head of investor relations and former Industry Super Australia (ISA) chief executive, David Whiteley responded to Wilson claiming the Aurora Research report allegations were “false and misleading”.

“The allegations in the report referenced by the Committee are false and misleading,” Whiteley’s formal letter of response said.

“Ensuring the valuations of IFM’s portfolio companies are completed independently, appropriately and in compliance with applicable accounting standards is critically important.

“Valuations of IFM’s portfolio companies are performed quarterly by independent, expert third-party valuation firms, and are conducted in compliance with international accounting standards such as US Generally Accepted Accounting Principles (US GAAP) and International Financial Reporting Standards (IFRS).

“A different independent valuation firm is appointed to value each of IFM’s investments every three years. In the case of IFM’s investment in Aleatica, two expert valuation firms have analysed the investment over time and have independently determined appropriate methodologies to establish their valuations, which must comply with the applicable accounting standards.”

“Further, IFM’s corporate auditor (currently Deloitte) reviews all of the independent valuations of IFM’s investments on an annual basis to ensure compliance with the applicable accounting standards. Deloitte does not act as the independent valuation firm for any of IFM’s investments in its portfolio companies,” Whiteley’s response said.

Recommended for you




Did Whitely acutally answer the question. Surely the correct market valuation is the daily share price

As much as it pains me to agree with you Peter as I have met you before and was not impressed, in this situation you may be right.

Wilson should vigorously be pursuing their methodology as inaccurate. "Every three years' and 'over time' cannot be a true reflection of the intrinsic value of a listed asset, otherwise the markets themselves would be redundant.

Clearly this is a case of misrepresentative reporting at the best or more accurately, fraud on IFM's behalf.

Koolum what was the use of your first sentence, what a horrible thing to say, at least have the guts to put your name to such a personal insult. Very unprofessional.

Poor little poppet, want my tissue?

No thanks, i'd much rather have a decent conversation with likeminded professional people, unfortunately that rules you out.

Maybe the right question is the quantum of fees paid to Deloitte for their'independent' valuation methodology. If Deloitte believe Aleatica is valued at $3.79 but listed at $1.52 it must be a screaming buy and IFM should buy more. We can just watch as the price ramps up based on their expert opinion...?

Thanks "Koolum." At least I've put my name to the comments. Have a great day. Agree with Paul's comemtns.

Get unions and Labor out of super

Add new comment